Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $27,740 | 756 | 95.7% |
| Travel and Lodging | $1,010 | 5 | 3.5% |
| Education | $224.95 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $12,453 | 161 | $0 (2024) |
| Boston Scientific Corporation | $2,197 | 46 | $0 (2023) |
| Amgen Inc. | $1,432 | 87 | $0 (2024) |
| ABIOMED | $1,428 | 23 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,327 | 86 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,226 | 41 | $0 (2024) |
| Inari Medical, Inc. | $1,187 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $800.87 | 54 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $670.21 | 32 | $0 (2024) |
| BIOTRONIK INC. | $664.37 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,792 | 111 | Inari Medical, Inc. ($408.88) |
| 2023 | $3,151 | 97 | Abbott Laboratories ($624.42) |
| 2022 | $2,431 | 94 | Abbott Laboratories ($479.99) |
| 2021 | $3,426 | 124 | Abbott Laboratories ($700.10) |
| 2020 | $946.44 | 37 | Abbott Laboratories ($332.16) |
| 2019 | $3,321 | 60 | Abbott Laboratories ($1,788) |
| 2018 | $6,542 | 115 | Abbott Laboratories ($4,112) |
| 2017 | $6,364 | 126 | Abbott Laboratories ($4,199) |
All Payment Transactions
764 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $148.39 | General |
| Category: Lithoplasty | ||||||
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/06/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $53.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 11/13/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: VTE | ||||||
| 11/13/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: VTE | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $138.84 | General |
| Category: VTE | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: Heart Failure | ||||||
| 10/09/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Not Applicable | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/26/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $30.42 | General |
| Category: Not Applicable | ||||||
| 09/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/20/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,410 | 2,975 | $472,904 | $154,362 |
| 2022 | 28 | 2,068 | 2,655 | $433,968 | $132,643 |
| 2021 | 30 | 2,041 | 2,677 | $469,154 | $145,137 |
| 2020 | 21 | 1,269 | 1,643 | $298,627 | $93,991 |
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 394 | 582 | $119,964 | $53,928 | 45.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 314 | 317 | $64,985 | $16,082 | 24.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 82 | 98 | $27,244 | $13,197 | 48.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $24,640 | $8,893 | 36.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 41 | 42 | $41,286 | $8,551 | 20.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 49 | 86 | $17,372 | $7,952 | 45.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 436 | 600 | $36,000 | $6,390 | 17.7% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 11 | 15 | $27,060 | $5,697 | 21.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 71 | $10,011 | $4,396 | 43.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 27 | $10,611 | $3,524 | 33.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 60 | 60 | $14,160 | $3,477 | 24.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 35 | 36 | $5,472 | $2,569 | 47.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $6,432 | $2,427 | 37.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 239 | 359 | $9,693 | $2,330 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 30 | $4,170 | $1,965 | 47.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 36 | 36 | $3,312 | $1,514 | 45.7% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 17 | 17 | $5,678 | $1,445 | 25.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 93 | 93 | $6,510 | $1,431 | 22.0% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 23 | 23 | $6,394 | $1,418 | 22.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 23 | $1,932 | $1,044 | 54.0% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 12 | 12 | $4,680 | $1,039 | 22.2% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 14 | 14 | $7,588 | $1,024 | 13.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 19 | 19 | $3,895 | $1,009 | 25.9% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 53 | 53 | $4,187 | $822.64 | 19.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 62 | 62 | $2,914 | $681.10 | 23.4% |
About Dr. Itamar Birnbaum, M.D
Dr. Itamar Birnbaum, M.D is a Interventional Cardiology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2012. The National Provider Identifier (NPI) number assigned to this provider is 1811254857.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Itamar Birnbaum, M.D has received a total of $28,975 in payments from pharmaceutical and medical device companies, with $2,792 received in 2024. These payments were reported across 764 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($27,740).
As a Medicare-enrolled provider, Birnbaum has provided services to 7,788 Medicare beneficiaries, totaling 9,950 services with total Medicare billing of $526,133. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Austin, TX
- Active Since 04/16/2012
- Last Updated 07/12/2019
- Taxonomy Code 207RI0011X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811254857
Products in Payments
- Assurity Pacemaker (Device) $1,762
- CRT-Ds (Device) $1,741
- Impella (Device) $1,428
- Pacemakers (Device) $1,357
- XARELTO (Drug) $1,327
- Quadra Assura CRT Defibrillator (Device) $1,319
- FLOWTRIEVER CATHETER, S (Device) $1,187
- Repatha (Biological) $1,083
- BRILINTA (Drug) $992.81
- LifeVest (Device) $670.21
- ENTRESTO (Drug) $636.82
- Fortify Assura, Ellipse ICD (Device) $630.28
- SYNERGY (Device) $548.79
- Accent Pacemaker (Device) $526.66
- Ozempic (Drug) $505.45
- ASSURITY (Device) $465.42
- Quadra Allure MP RF CRT Pacemkr (Device) $457.92
- ELIQUIS (Drug) $440.28
- Allure Quadra RF CRT Pacemaker (Device) $417.06
- EnSite Precision Cardiac Mapping System (Device) $406.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Austin
Dr. Edward Chafizadeh, M.d, M.D
Interventional Cardiology — Payments: $46,268
Dr. Michael Grad, M.d, M.D
Interventional Cardiology — Payments: $41,609
Dr. Manish Chauhan, M.d, M.D
Interventional Cardiology — Payments: $34,654
Dr. Robert Wozniak, Md, MD
Interventional Cardiology — Payments: $30,046
Dr. Paul Roach, M.d, M.D
Interventional Cardiology — Payments: $19,366
Mark Pirwitz, Md, Facc, MD, FACC
Interventional Cardiology — Payments: $19,081